影像学在肾癌靶向治疗中的临床应用价值- 现状与展望.

Renal cancer is the most common renal cancer, which is easy to relapse and distant metastasis. Targeted therapy has gradually become an indispensable treatment for renal cancer. Because of the limitation of the RECIST standard in evaluating the effect of solid tumors, computed tomograhy(CT) and Magnetic Resonance Imaging(MRI) are often used in clinical practice. With the continuous development of technology, many new imaging methods, such as dynamic contrast-enhanced ultra sonography(DCE-US), positron emission tomography CT (PET-CT), can more accurately and early evaluate and predict the efficacy of targeted therapy. In this paper, the imaging status and prospect of targeted therapy for renal cancer were reviewed. [ABSTRACT FROM AUTHOR]